#diagnostics #colorectalcancer #Tagomics #colorectalcancertest #Biotech #NHS #InnovateUK #BiomedicalCatalystprogramme #Interlaceplatform #biomarkers #epigeneticmarkers #epigeneticprofiling #multiomicworkflow #AgilentTechnologies #SureSelect #multiomicprofiling
pharmatimes.com/news/tagomic...
pharmatimes.com/news/tagomic...
Tagomics secures £860k grant for colorectal cancer test - PharmaTimes
Biotech firm to collaborate with NHS on early detection study
pharmatimes.com
June 11, 2025 at 8:27 AM
A phase 1b/2 trial shows that #allogeneic #NKcell therapy plus #chemotherapy is safe in #AdvancedPancreaticCancer, with 31.6% response; #MultiomicProfiling reveals NK/T‑cell subsets linked to outcomes, offering novel immune insights.
#OpenAccess in STTT: doi.org/10.1038/s413...
#OpenAccess in STTT: doi.org/10.1038/s413...
January 28, 2026 at 4:07 PM
A phase 1b/2 trial shows that #allogeneic #NKcell therapy plus #chemotherapy is safe in #AdvancedPancreaticCancer, with 31.6% response; #MultiomicProfiling reveals NK/T‑cell subsets linked to outcomes, offering novel immune insights.
#OpenAccess in STTT: doi.org/10.1038/s413...
#OpenAccess in STTT: doi.org/10.1038/s413...
Multi-omic profiling of atherosclerosis: protocol and pilot data for the AtherOMICS biobank
Alabarse, P. V. G., Antabi, M. A. et al.
Paper
Details
#AtherOMICS #MultiOmicProfiling #AtherosclerosisResearch
Alabarse, P. V. G., Antabi, M. A. et al.
Paper
Details
#AtherOMICS #MultiOmicProfiling #AtherosclerosisResearch
June 19, 2025 at 9:02 AM
Multi-omic profiling of atherosclerosis: protocol and pilot data for the AtherOMICS biobank
Alabarse, P. V. G., Antabi, M. A. et al.
Paper
Details
#AtherOMICS #MultiOmicProfiling #AtherosclerosisResearch
Alabarse, P. V. G., Antabi, M. A. et al.
Paper
Details
#AtherOMICS #MultiOmicProfiling #AtherosclerosisResearch